Rhythm Pharmaceuticals Inc (RYTM)
41.51
+1.71
(+4.30%)
USD |
NASDAQ |
May 01, 16:00
41.51
0.00 (0.00%)
After-Hours: 19:28
Rhythm Pharmaceuticals Net Income (TTM): -184.68M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -184.68M |
| September 30, 2023 | -185.54M |
| June 30, 2023 | -182.24M |
| March 31, 2023 | -180.53M |
| December 31, 2022 | -181.12M |
| September 30, 2022 | -181.49M |
| June 30, 2022 | -175.74M |
| March 31, 2022 | -166.13M |
| December 31, 2021 | -69.61M |
| September 30, 2021 | -61.64M |
| June 30, 2021 | -60.35M |
| March 31, 2021 | -56.08M |
| December 31, 2020 | -134.00M |
| September 30, 2020 | -132.06M |
| Date | Value |
|---|---|
| June 30, 2020 | -134.24M |
| March 31, 2020 | -145.92M |
| December 31, 2019 | -140.73M |
| September 30, 2019 | -133.28M |
| June 30, 2019 | -114.96M |
| March 31, 2019 | -86.58M |
| December 31, 2018 | -74.06M |
| September 30, 2018 | -59.09M |
| June 30, 2018 | -51.42M |
| March 31, 2018 | -43.81M |
| December 31, 2017 | -33.71M |
| September 30, 2017 | -31.54M |
| June 30, 2017 | -27.92M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-185.54M
Minimum
Sep 2023
-56.08M
Maximum
Mar 2021
-137.91M
Average
-140.73M
Median
Dec 2019
Net Income (TTM) Benchmarks
| Pfizer Inc | 2.119B |
| Insmed Inc | -749.57M |
| Altimmune Inc | -88.45M |
| Regeneron Pharmaceuticals Inc | 3.954B |
| Viking Therapeutics Inc | -93.72M |